Source: ClinicalTrials.gov — U.S. National Library of Medicine — A database of privately and publicly funded clinical studies conducted around the world (U.S. National Library of Medicine, public domain).
This page lists clinical trials related to Metabolic Syndrome from the ClinicalTrials.gov database.
Trial Summary
- Total studies: 50
- Recruiting: 21
- Active, not recruiting: 7
- Completed: 6
- Other: 16
Results are refreshed periodically and may not reflect the most current information available from ClinicalTrials.gov.
Recruiting Trials
NCT00001456 — Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome
| Status | Recruiting |
| Phase | N/A |
| Sponsor | National Human Genome Research Institute (NHGRI) |
| Enrollment | 600 |
| Study Type | OBSERVATIONAL |
| Conditions | Hermansky-Pudlak Syndrome (HPS) |
Hermansky-Pudlak Syndrome (HPS) is an inherited disease which results in decreased pigmentation (oculocutaneous albinism), bleeding problems due to a platelet abnormality (platelet storage pool defect), and storage of an abnormal fat-protein compound (lysosomal accumulation of ceroid lipofuscin).
The disease can cause poor functioning of the lungs, intestine, kidneys, or heart. The major compl…
NCT00027274 — Cancer in Inherited Bone Marrow Failure Syndromes
| Status | Recruiting |
| Phase | N/A |
| Sponsor | National Cancer Institute (NCI) |
| Enrollment | 4000 |
| Study Type | OBSERVATIONAL |
| Conditions | Diamond Blackfan Anemia; Dyskeratosis Congenita; Fanconi Anemia; Shwachman Diamond Syndrome; Inherited Bone Marrow Failure Syndrome, Aplastic Anemia |
Background:
A prospective cohort of Inherited Bone Marrow Failure Syndrome (IBMFS) will provide new information regarding cancer rates and types in these disorders.
Pathogenic variant(s) in IBMFS genes are relevant to carcinogenesis in sporadic cancers.
Patients with IBMFS who develop cancer differ in their genetic and/or environmental features from patients with IBMFS who do not develop can…
NCT00055172 — Genetic Basis of Immunodeficiency
| Status | Recruiting |
| Phase | N/A |
| Sponsor | National Heart, Lung, and Blood Institute (NHLBI) |
| Enrollment | 100 |
| Study Type | OBSERVATIONAL |
| Conditions | Severe Combined Immunodeficiency |
This study will examine the role of hereditary factors in different forms of severe combined immunodeficiency (SCID).
Patients with immunodeficiencies may be eligible for this study. Candidates include:
- Patients with diminished numbers of T cells or NK cells or both, or
- Patients with normal T cell and NK cell numbers but diminished T cell, B cell, or NK cell function.
Relatives of patien…
NCT00078078 — Clinical and Laboratory Study of Methylmalonic Acidemia
| Status | Recruiting |
| Phase | N/A |
| Sponsor | National Human Genome Research Institute (NHGRI) |
| Enrollment | 2275 |
| Study Type | OBSERVATIONAL |
| Conditions | Organic Acidemia; Methylmalonic Acidemia; Inborn Errors of Metabolism |
Methylmalonic acidemia (MMA), one of the most common inborn errors of organic acid metabolism, is heterogeneous in etiology and clinical manifestations. Affected patients with cblA, cblB and mut classes of MMA are medically fragile and can suffer from complications such as metabolic stroke or infarction of the basal ganglia, pancreatitis, end stage renal failure, growth impairment, osteoporosis…
NCT00250159 — Natural History Study of Patients With Excess Androgen
| Status | Recruiting |
| Phase | N/A |
| Sponsor | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
| Enrollment | 3000 |
| Study Type | OBSERVATIONAL |
| Conditions | Congenital Adrenal Hyperplasia (CAH); Familial Male-Limited Precocious Puberty (FMPP) |
This study will evaluate and gather information in patients with genetic causes of too much androgen (male-like hormone) in order to better understand the effects of too much androgen and describe problems associated with it. Too much androgen in childhood, if untreated, results in rapid growth and early puberty with early cessation of growth and short stature in adulthood. Too much androgen in…
NCT01143454 — Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
| Status | Recruiting |
| Phase | N/A |
| Sponsor | National Heart, Lung, and Blood Institute (NHLBI) |
| Enrollment | 5000 |
| Study Type | OBSERVATIONAL |
| Conditions | Metabolic Disease; Obesity; Li-Fraumeni Syndrome; Cardiomyopathy; Atherosclerosis |
| Interventions |
Background:
- Researchers are interested in studying individuals who have known or suspected metabolic, inflammatory or genetic diseases that may put them at a high risk for heart diseases or diseases of their blood vessels. Depending on the condition being studied, both affected and nonaffected individuals may be asked to provide blood and other samples and may undergo tests to evaluate the …
NCT01443468 — Clinical and Genetic Studies of Li-Fraumeni Syndrome
| Status | Recruiting |
| Phase | N/A |
| Sponsor | National Cancer Institute (NCI) |
| Enrollment | 5000 |
| Study Type | OBSERVATIONAL |
| Conditions | Li-Fraumeni Syndrome; Neoplasms; Tp53 Mutations |
Background:
- Li-Fraumeni syndrome (LFS) is a genetic condition that increases the risk for some types of cancer. LFS may lead to cancer of the bone or connective tissue, breast, and brain. It may also increase the risk for certain types of leukemia and other cancers. The only known cause of LFS is a change (called a mutation ) in a gene known as TP53. However, not all people with LFS have a …
NCT01666080 — Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
| Status | Recruiting |
| Phase | N/A |
| Sponsor | Masonic Cancer Center, University of Minnesota |
| Enrollment | 30 |
| Study Type | INTERVENTIONAL |
| Conditions | Hematologic Disorders; Hemoglobinopathies; Immunodeficiencies |
| Interventions | ; ; |
This is a treatment guideline for a second or greater allogeneic hematopoietic stem cell transplant (HSCT) using a reduced intensity conditioning (RIC) in patients with non-malignant or malignant diseases. This regimen, consisting of busulfan, fludarabine, and low dose total body irradiation (TBI), is designed to promote engraftment in patients who failed to achieve an acceptable level of donor…
NCT03049462 — The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor Agonists
| Status | Recruiting |
| Phase | Phase 1 |
| Sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
| Enrollment | 100 |
| Study Type | INTERVENTIONAL |
| Conditions | Polycystic Ovary Syndrome |
| Interventions | ; |
Background:
Brown adipose tissue (BAT) is a type of fat in the body. It may prevent weight gain, improve insulin sensitivity, and reduce fatty liver. Researchers want to see if BAT helps the body burn energy.
Objective:
To learn more about how BAT works to burn energy.
Eligibility:
People ages 18-40 with a body mass index between 18 and 40
Design:
Participants will be screened with:
Med…
NCT03530852 — A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB
| Status | Recruiting |
| Phase | N/A |
| Sponsor | Boston Children’s Hospital |
| Enrollment | 32 |
| Study Type | INTERVENTIONAL |
| Conditions | Short Bowel Syndrome; Malabsorption |
| Interventions |
Children with inadequate intestinal absorption due to loss of large amounts of small bowel require intravenous nutrition (feeding through the vein) to sustain hydration and nutrition to avoid starvation and dehydration; however, intravenous (IV) nutrition can lead to complications including liver failure. Tube feeding directly to the small intestine avoids the complications of IV nutrition, but…
NCT03805919 — Men at High Genetic Risk for Prostate Cancer
| Status | Recruiting |
| Phase | N/A |
| Sponsor | National Cancer Institute (NCI) |
| Enrollment | 500 |
| Study Type | OBSERVATIONAL |
| Conditions | Prostatic Neoplasms |
Background:
Research studies have shown that genetic changes and family history may increase a man s risk for prostate cancer. Researchers want to follow the prostate health of men who have specific genetic changes associated with prostate cancer to help them learn more about which men are at higher risk for prostate cancer.
Objectives:
To study men with specific genetic changes and determin…
NCT04414046 — TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
| Status | Recruiting |
| Phase | Phase 2 |
| Sponsor | Johns Hopkins All Children’s Hospital |
| Enrollment | 17 |
| Study Type | INTERVENTIONAL |
| Conditions | Primary Immune Deficiency Disorders; Metabolic Disease |
| Interventions |
This research is being done to learn if a new type of haploidentical transplantation using TCR alpha beta and CD19 depleted stem cell graft from the donor is safe and effective to treat the patient’s underlying condition. This study will use stem cells obtained via peripheral blood or bone marrow from parent or other half-matched family member donor. These will be processed through a special de…
NCT05047354 — Biochemical and Phenotypical Aspects of Smith-Lemli-Opitz Syndrome and Related Disorders of Cholesterol Metabolism
| Status | Recruiting |
| Phase | N/A |
| Sponsor | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
| Enrollment | 250 |
| Study Type | OBSERVATIONAL |
| Conditions | Smith Lemli Opitz Syndrome; CHILD Syndrome; Lathosterolosis; Desmosterolosis |
Background:
Smith-Lemli-Opitz Syndrome (SLOS) is a genetic disorder. It can cause birth defects and developmental delays. There is no cure for SLOS or other inherited diseases related to cholesterol production or storage. The data gained in this study may help researchers find ways to measure how well future treatments work.
Objective:
To learn more about SLOS and related disorders and how t…
NCT05791604 — The Intervention of Obesity in Children With Prader-Willi Syndrome Using Prebiotics and Probiotics
| Status | Recruiting |
| Phase | N/A |
| Sponsor | Children’s Hospital of Fudan University |
| Enrollment | 60 |
| Study Type | INTERVENTIONAL |
| Conditions | Prader-Willi Syndrome |
| Interventions | ; |
Prader-Willi syndrome (PWS) is a rare genetic disease, with hyperappetite and severe obesity. At present, there is no effective drugs and interventions to help control the appetite of PWS patients. More and more evidence has shown that gut microbiota is closely related to obesity. Probiotics and prebiotics can improve the structure of gut microbiota, thus improve blood lipid levels and other bi…
NCT05705804 — Effects of Pitavastatin or Combination of Pitavastatin and Ezetimibe on Glucose Metabolism Compared to AtoRvastatin in atheroscLerotic Cardiovascular Disease Patients With Metabolic Syndrome: The EZ-PEARL Randomized Trial
| Status | Recruiting |
| Phase | N/A |
| Sponsor | Yonsei University |
| Enrollment | 250 |
| Study Type | INTERVENTIONAL |
| Conditions | Dyslipidemias; Atherosclerotic Cardiovascular Disease |
| Interventions | ; ; |
The purpose of this study was to investigate the effect of pitavastatin or pitavastatin and ezetimibe combination therapy on glucose metabolism compared to atorvastatin in patients with atherosclerotic cardiovascular disease with metabolic syndrome.
NCT06500078 — Effects of Intermittent Dietary Restriction on Cardiometabolic Risk in School-aged Children
| Status | Recruiting |
| Phase | N/A |
| Sponsor | Children’s Hospital of Fudan University |
| Enrollment | 324 |
| Study Type | INTERVENTIONAL |
| Conditions | Cardiovascular Syndrome, Metabolic |
| Interventions | ; |
This randomized trial aims to evaluate the health-promoting effects of intermittent dietary restrictions, including intermittent low-carbohydrate diet (ILCD) and calorie restriction (ICR), in school-aged children with cardiometabolic risk (CMR) compared with general health education based on dietary and physical activity guidelines for Chinese children.
NCT07159841 — A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)
| Status | Recruiting |
| Phase | Phase 2 / Phase 3 |
| Sponsor | Crinetics Pharmaceuticals Inc. |
| Enrollment | 153 |
| Study Type | INTERVENTIONAL |
| Conditions | Congenital Adrenal Hyperplasia; Classic Congenital Adrenal Hyperplasia |
| Interventions | ; |
The purpose of this study is to evaluate the safety, efficacy, pharmacokinetics (PK), and pharmacodynamics (PD) of atumelnant treatment in pediatric participants with classic congenital adrenal hyperplasia (CAH).
NCT07369011 — A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
| Status | Recruiting |
| Phase | Phase 3 |
| Sponsor | Eli Lilly and Company |
| Enrollment | 800 |
| Study Type | INTERVENTIONAL |
| Conditions | Sleep Apnea, Obstructive; Obesity; Overweight |
| Interventions | ; |
The purpose of the studies is to evaluate the efficacy and safety of eloralintide in participants with moderate-to-severe obstructive sleep apnea and obesity or overweight. YDAO is a master protocol designed to support two independent studies: YSA1 and YSA2. Study YSA1 will include participants who are unable or unwilling to use Positive Airway Pressure (PAP) therapy and study YSA2 will include…
NCT07571915 — Health-Related Quality of Life and Metabolic Outcomes in PCOS
| Status | Recruiting |
| Phase | N/A |
| Sponsor | The Cleveland Clinic |
| Enrollment | 40 |
| Study Type | INTERVENTIONAL |
| Conditions | PCOS (Polycystic Ovary Syndrome) |
| Interventions |
The primary outcome of interest is change in PCOS health-related quality of life, while the secondary outcome of interest is change in adiposity, cardiometabolic, and inflammation biomarkers.
NCT07636928 — Mass Balance and Absolute Oral Bioavailability of [14C]VH4524184
| Status | Recruiting |
| Phase | Phase 1 |
| Sponsor | ViiV Healthcare |
| Enrollment | 9 |
| Study Type | INTERVENTIONAL |
| Conditions | HIV Infections |
| Interventions | ; ; |
The purpose of the study is to assess the bioavailability, mass balance, pharmacokinetics, metabolism and excretion of radiolabeled (14C) VH4524184.
NCT07649031 — MRI as Noninvasive Innovative Approach in Detection and Monitoring of Malignant Oral Lesions in Fanconi Anemia Patients
| Status | Recruiting |
| Phase | N/A |
| Sponsor | University of Minnesota |
| Enrollment | 80 |
| Study Type | OBSERVATIONAL |
| Conditions | Fanconi Anemia |
| Interventions |
This study being done to learn more about the use of medical Magnetic Resonance Imaging (mMRI) and dedicated dental MRI (ddMRI) as a non-invasive diagnosing tool when evaluating potential oral cancerous and precancerous lesions in Fanconi Anemia patients.
Active, Not Recruiting
NCT00084305 — Analysis of Specimens From Individuals With Pulmonary Fibrosis
| Status | Active, not recruiting |
| Phase | N/A |
| Sponsor | National Human Genome Research Institute (NHGRI) |
| Enrollment | 315 |
| Study Type | OBSERVATIONAL |
| Conditions | Pulmonary Fibrosis; Healthy Volunteers; Hermansky-Pudlak Syndrome (HPS) |
The etiology of pulmonary fibrosis is unknown. Analyses of blood, genomic DNA, and specimens procured by bronchoscopy, lung biopsy, lung transplantation, clinically-indicated extra-pulmonary biopsies, or post-mortem examination from individuals with this disorder may contribute to our understanding of the pathogenic mechanisms of pulmonary fibrosis. The purpose of this protocol is to procure an…
NCT02912559 — Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
| Status | Active, not recruiting |
| Phase | Phase 3 |
| Sponsor | National Cancer Institute (NCI) |
| Enrollment | 712 |
| Study Type | INTERVENTIONAL |
| Conditions | Colon Adenocarcinoma; DNA Repair Disorder; Lynch Syndrome; Stage III Colon Cancer AJCC v8 |
| Interventions | ; ; |
This phase III trial studies combination chemotherapy and atezolizumab to see how well it works compared with combination chemotherapy alone in treating patients with stage III colon cancer and deficient deoxyribonucleic acid (DNA) mismatch repair (dMMR). Drugs used in combination chemotherapy, such as oxaliplatin, leucovorin calcium, and fluorouracil, work in different ways to stop the growth …
NCT03655223 — Early Check: Expanded Screening in Newborns
| Status | Active, not recruiting |
| Phase | N/A |
| Sponsor | RTI International |
| Enrollment | 30000 |
| Study Type | OBSERVATIONAL |
| Conditions | Spinal Muscular Atrophy; Fragile X Syndrome; Fragile X - Premutation; Duchenne Muscular Dystrophy; Hyperinsulinemic Hypoglycemia, Familial 1 |
| Interventions |
Early Check provides voluntary screening of newborns for a selected panel of conditions. The study has three main objectives: 1) develop and implement an approach to identify affected infants, 2) address the impact on infants and families who screen positive, and 3) evaluate the Early Check program. The Early Check screening will lead to earlier identification of newborns with rare health condi…
NCT05003648 — Treating Leg Symptoms in Women With X-linked Adrenoleukodystrophy
| Status | Active, not recruiting |
| Phase | Phase 4 |
| Sponsor | Massachusetts General Hospital |
| Enrollment | 24 |
| Study Type | INTERVENTIONAL |
| Conditions | Adrenoleukodystrophy; Restless Legs Syndrome |
| Interventions | ; |
The investigators recently observed that up to 25% of women with X-linked adrenoleukodystrophy (ALD) have moderate to severe Restless Leg Syndrome (RLS). In this study, the investigators aim to estimate the prevalence of RLS among women with ALD and to assess whether pramipexole improves RLS symptoms as well as sleep and gait measures in women with ALD.
NCT05632601 — Reexamining Her Cardiovascular Risk - Ottawa WomeN’s Longitudinal Cohort Study
| Status | Active, not recruiting |
| Phase | N/A |
| Sponsor | Ottawa Heart Institute Research Corporation |
| Enrollment | 176 |
| Study Type | INTERVENTIONAL |
| Conditions | Cardiovascular Diseases |
| Interventions |
The full HER CROWN will be a prospective cohort study to propose a novel, women-specific cardiovascular risk score/ algorithm in the prediction of hard cardiovascular outcomes (myocardial infarction, unstable angina, coronary revascularization, stroke, total and cardiovascular mortality). This future study will be the first longitudinal cohort study, to our knowledge, that is focused entirely o…
NCT06807463 — A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac Disease
| Status | Active, not recruiting |
| Phase | Phase 2 |
| Sponsor | Teva Branded Pharmaceutical Products R&D LLC |
| Enrollment | 50 |
| Study Type | INTERVENTIONAL |
| Conditions | Celiac Disease |
| Interventions | ; |
The primary efficacy objective of the trial is to assess the ability of TEV-53408 to attenuate gluten-induced enteropathy in adults with celiac disease.
The primary safety objective of the trial is to assess the safety of TEV-53408 in adults with celiac disease.
A secondary objective is to further assess the efficacy of TEV-53408 in adults with celiac disease.
The expected trial duration per…
NCT06961344 — An Open-label Extension Safety Study of MELAS Patients Who Completed TIS6463-203 (PRIZM)
| Status | Active, not recruiting |
| Phase | Phase 2 |
| Sponsor | Tisento Therapeutics |
| Enrollment | 44 |
| Study Type | INTERVENTIONAL |
| Conditions | Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome) |
| Interventions |
The goal of this clinical trial is to evaluate the long-term safety and tolerability of zagociguat in patients with MELAS who completed study medication treatment in the lead-in study TIS6463-203. TIS6463-204 is evaluating zagociguat in an open-label extension study at the daily dose of 15mg. The study medication is a once daily oral table and will be provided at the clinic and/or shipped to th…
Not Yet Recruiting
NCT07688265 — Effect of Obesity Phenotype on Intraabdominal Pressure and Bleeding in Major Lumbar Spinal Surgery
| Status | Not yet recruiting |
| Phase | N/A |
| Sponsor | Marmara University Pendik Training and Research Hospital |
| Enrollment | 90 |
| Study Type | OBSERVATIONAL |
| Conditions | Lumbar Spinal Stenosis; Lumbar Degenerative Disease; Obesity; Intraabdominal Hypertension; Intraoperative Blood Loss |
| Interventions | ; |
Obesity is prevalent among patients with lumbar degenerative disease and is a known risk factor for perioperative complications in spinal surgery. However, most existing evidence relies solely on body mass index (BMI) without distinguishing between central and peripheral obesity phenotypes. Central and peripheral fat distribution may have distinct biomechanical and hemodynamic consequences, par…
NCT07684469 — Comparative Assessment of Inclisiran on Top of Standard of Care Versus Standard of Care Alone for LDL-C Evaluation in Acute Coronary Syndrome Patients in Saudi Arabia
| Status | Not yet recruiting |
| Phase | Phase 4 |
| Sponsor | Novartis Pharmaceuticals |
| Enrollment | 300 |
| Study Type | INTERVENTIONAL |
| Conditions | Acute Coronary Syndrome |
| Interventions | ; |
This study aims to evaluate the effectiveness and safety of implementing a systematic augmented low-density lipoprotein cholesterol (LDL-C) management care pathway initiated in hospitals for patients with Acute Coronary Syndrome. This pathway includes treatment with inclisiran on top of the standard of care (SOC), which consists of statins with or without ezetimibe, compared to a high-intensity…
NCT07611786 — Development of Healthcare Transition for Patients With Congenital Adrenal Hyperplasia
| Status | Not yet recruiting |
| Phase | N/A |
| Sponsor | University of Alabama at Birmingham |
| Enrollment | 40 |
| Study Type | OBSERVATIONAL |
| Conditions | Congenital Adrenal Hyperplasia |
| Interventions |
The purpose of this study is to implement and evaluate the feasibility and acceptability of a structured healthcare transition program for adolescents and young adults with congenital adrenal hyperplasia (CAH). The study will also examine preliminary effects of the program on transition readiness, disease-specific self-management knowledge, emergency preparedness, continuity of endocrine care, …
NCT07687667 — Effects of GLP-1RAs on Fertility Outcomes in Obese Women With PCOS
| Status | Not yet recruiting |
| Phase | N/A |
| Sponsor | Peking University Third Hospital |
| Enrollment | 406 |
| Study Type | INTERVENTIONAL |
| Conditions | Polycystic Ovary Syndrome (PCOS); Obesity; Infertility, Female |
| Interventions | ; |
The goal of this clinical trial is to examine whether GLP1-RA and healthy lifestyle education in women with PCOS and obesity prior to fertility treatment improves live birth rate and other reproductive, maternal and perinatal outcomes compared to metformin plus healthy lifestyle education.
NCT07005297 — Clinical Genetics Branch Eligibility Screening Survey
| Status | Not yet recruiting |
| Phase | N/A |
| Sponsor | National Cancer Institute (NCI) |
| Enrollment | 1000 |
| Study Type | OBSERVATIONAL |
| Conditions | Melanoma; Li-Fraumeni Syndrome; Pulmonary Blastoma; Chordoma; Congenital Bone Marrow Failure Syndromes |
Background:
Clinical Genetics Branch (CGB) researchers study individuals and populations at high genetic risk of cancer in order to improve our understanding of cancer and to improve cancer care. There are currently 6 open clinical genetics studies at the CGB eligible for this screening process.
- 02C0052: Etiologic Investigation of Cancer Susceptibility in Inherited Bone Marrow Failure Syndr…
NCT07313787 — Effects of Meal Macronutrients on Postprandial Lipids
| Status | Not yet recruiting |
| Phase | Phase 2 |
| Sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
| Enrollment | 100 |
| Study Type | INTERVENTIONAL |
| Conditions | Nephrotic Syndrome; Lipodystrophy; Metabolic Syndrome; Healthy Volunteer; Diabetes |
| Interventions | ; |
Background:
Abnormal fats in the blood can lead to many problems, including heart disease. Researchers want to learn more about how eating meals with different levels of nutrients affects fats in the blood. Specifically, they want to study people with too much body fat, too little body fat, and a kidney problem called nephrotic syndrome.
Objective:
To learn more about how different types of …
NCT07680816 — Metabolic and Functional Study of γδ T Cells in Critically Ill Patients
| Status | Not yet recruiting |
| Phase | N/A |
| Sponsor | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology |
| Enrollment | 105 |
| Study Type | OBSERVATIONAL |
| Conditions | Sepsis; Critical Illness; Immunosuppression; MODS; Mitochondrial Diseases |
This prospective observational cohort study investigates the subset-specific metabolic adaptation and functional remodeling of cytotoxic γδT cells in critically ill patients with and without sepsis. Emerging evidence indicates that γδT cells, as a bridge between innate and adaptive immunity, play a critical role in early anti-infection defense during sepsis. However, the functional status and u…
NCT07240649 — Emerging Indications for Hyperbaric Oxygen Treatment
| Status | Not yet recruiting |
| Phase | Phase 4 |
| Sponsor | Jay C. Buckey Jr. |
| Enrollment | 100 |
| Study Type | INTERVENTIONAL |
| Conditions | Post-COVID-19 Condition; Ulcerative Colitis; Crohn Disease; Calciphylaxis; Frostbite |
| Interventions | ; |
This study will evaluate the effectiveness of hyperbaric oxygen therapy (HBOT) on treating emerging indications (i.e., conditions that have shown to potentially benefit from HBOT) using the Multicenter Registry for Hyperbaric Oxygen Treatment. The study team aims to collect ongoing data on how well HBOT treats these emerging indications, and to add these data to the growing HBO Registry. The re…
NCT07685639 — Electronic Health Record Augmented LDL-Cholesterol Optimization and Control Via Active Lipid Engagement (EHR-LOCALE): A Quality Improvement Implementation Study
| Status | Not yet recruiting |
| Phase | N/A |
| Sponsor | University of Alberta |
| Enrollment | 2000 |
| Study Type | INTERVENTIONAL |
| Conditions | ACS (Acute Coronary Syndrome); Hyperlipidemia; Dyslipidemia; Low-Density-Lipoprotein-cholesterol Level |
| Interventions |
The purpose of this study is to determine whether a proactive, EHR-guided approach helps more individuals reach safe cholesterol levels, improves medication use, and reduces future heart attacks and strokes, compared to usual care.
The main question it aims to answer is:
• Does the EHR-LOCALE pathway increases the proportion of patients who reach the LDL-cholesterol target of <1.8 mmol/L at …
NCT07687264 — Assessment of Metabolic Changes in Response to Glcuose Intake in Women With Polyendocrine Metabolic Ovarian Syndrome (PMOS)
| Status | Not yet recruiting |
| Phase | N/A |
| Sponsor | University of Zurich |
| Enrollment | 40 |
| Study Type | INTERVENTIONAL |
| Conditions | PCOS (Polycystic Ovary Syndrome); Insulinemic Response; Overweight (BMI > 25) |
| Interventions |
Polyendocrine metabolic ovarian syndrome (PMOS), previously known as polycystic ovary syndrome (PCOS), is a common endocrine and metabolic condition affecting women of reproductive age. It is associated with hormonal imbalances, irregular menstrual cycles, elevated androgen levels, and metabolic disturbances such as insulin resistance. These metabolic changes can increase the risk of type 2 dia…
Enrolling by Invitation
NCT00895271 — Establishing Fibroblast-Derived Cell Lines From Skin Biopsies of Patients With Immunodeficiency or Immunodysregulation Disorders
| Status | Enrolling by invitation |
| Phase | N/A |
| Sponsor | National Institute of Allergy and Infectious Diseases (NIAID) |
| Enrollment | 200 |
| Study Type | OBSERVATIONAL |
| Conditions | Primary Immunodeficiency; DOCK8; Virus Susceptibility |
Background:
- National Institutes of Health (NIH) researchers have been studying immune cells (white blood cells) to better understand how the human body s defense system works and adjusts or regulates itself, and how changes in this system can make a person sick.
- To study the cells of patients who have problems with their immune systems, researchers would like to collect samples of skin cel…
NCT05635747 — A 90 Day Observational Study as an Extension to the Phase 3,Open Labeled Exploratory Study of RELiZORB
| Status | Enrolling by invitation |
| Phase | N/A |
| Sponsor | Boston Children’s Hospital |
| Enrollment | 32 |
| Study Type | OBSERVATIONAL |
| Conditions | Short Bowel Syndrome; Malabsorption |
| Interventions |
Children with inadequate intestinal absorption due to loss of large amounts of small bowel require intravenous nutrition (feeding through the vein) to sustain hydration and nutrition to avoid starvation and dehydration; however, intravenous (IV) nutrition can lead to complications including liver failure. Tube feeding directly to the small intestine avoids the complications of IV nutrition, but…
NCT07686601 — Metabolic Effectiveness of Extracorporeal Shockwave on Abdominal Adiposity
| Status | Enrolling by invitation |
| Phase | N/A |
| Sponsor | Cairo University |
| Enrollment | 90 |
| Study Type | INTERVENTIONAL |
| Conditions | Abdominal Obesity; Abdominal Obesity-Metabolic Syndrome; Abdominal Obesity in Young and Middle Aged Adults |
| Interventions | ; ; |
Egyptian Ministry of Health and Population’s Preventive Sector, have named obesity as one of the top contributors to the national mortality and morbidity. Abdominal obesity is a strong predictor of metabolic disorders and premature mortality. Visceral fat is metabolically active and sensitive for lipolysis, unless it is more insulin resistant. It is well-known that overweight and/ or obesity is…
NCT07688694 — Development of Anti-Diabetic Nutraceuticals From Legume Seed Coats
| Status | Enrolling by invitation |
| Phase | N/A |
| Sponsor | JSS MEDICAL COLLEGE, JSS ACADEMY OF HIGHER EDUCATION AND RESEARCH |
| Enrollment | 100 |
| Study Type | INTERVENTIONAL |
| Conditions | Postprandial Hyperglycemia; Type 2 Diabetes; Metabolic Syndromes |
| Interventions |
This open-label clinical trial aims to evaluate whether daily consumption of soup prepared from boiled water extracts of selected legume seed coats, seasoned with salt and spices, improves glycemic regulation in individuals with metabolic syndrome or type 2 diabetes mellitus (T2DM). The primary question is whether daily intake of this palatable legume-based soup enhances glycemic control. Secon…
Completed Trials
NCT00001721 — Study of Smith-Lemli-Opitz Syndrome
| Status | Completed |
| Phase | N/A |
| Sponsor | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
| Enrollment | 130 |
| Study Type | OBSERVATIONAL |
| Conditions | Smith-Lemli-Opitz Syndrome |
| Interventions | ; ; |
Smith-Lemli-Opitz Syndrome (SLOS) is a genetic disorder (autosomal recessive) caused by an abnormality in the production of cholesterol. The disorder can occur in both a “mild” or “severe” form. SLOS is associated with multiple birth defects and mental retardation. Some of the birth defects include; abnormal facial features, poor muscle tone, poor growth, shortened life span, and abnormalities …
NCT00001813 — Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
| Status | Completed |
| Phase | N/A |
| Sponsor | National Cancer Institute (NCI) |
| Enrollment | 709 |
| Study Type | OBSERVATIONAL |
| Conditions | Cockayne Syndrome; Skin Neoplasms; Xeroderma Pigmentosum; Trichothiodystrophy Syndromes; Genodermatosis |
Four rare genetic diseases, xeroderma pigmentosum (XP), Cockayne syndrome (CS), the XP/CS complex and trichothiodystrophy (TTD) have defective DNA excision repair although only XP has increased cancer susceptibility. We plan to perform careful clinical examination of selected patients with XP, XP/CS, CS, or TTD and follow their clinical course. We will obtain tissue (skin, blood, hair, buccal s…
NCT00040222 — Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
| Status | Completed |
| Phase | N/A |
| Sponsor | National Cancer Institute (NCI) |
| Enrollment | 377 |
| Study Type | OBSERVATIONAL |
| Conditions | Familial Ovarian Cancer; Familial Breast Cancer; BRCA1-associate Malignancies; BRCA2-associated Malignancies |
Individuals and families with known or suspected syndromes that include breast, ovarian or genetically-related cancers are enrolled in this family study, which is a syndrome-specific sub-set of the long-standing DCEG Human Genetics Program umbrella family studies protocol (78-C-0039). Cancer outcomes are documented through review of medical, vital, and pathology records. Selected individuals an…
NCT00046202 — Study of Inborn Errors of Cholesterol Synthesis and Related Disorders
| Status | Completed |
| Phase | N/A |
| Sponsor | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
| Enrollment | 342 |
| Study Type | OBSERVATIONAL |
| Conditions | Lysosomal Storage Disease; Cholesterol Metabolism |
This study will investigate the cause and medical problems associated with a group of genetic disorders known as inborn errors of cholesterol synthesis, in which the body does not produce cholesterol. People with this disorder may have birth defects and learning and behavioral problems.
People with an inborn error of cholesterol synthesis and related disorders, including Smith-Lemli-Opitz synd…
NCT07686939 — Clinical Validation of Continuous Glucose Monitoring in Glycemic Management of Critically Ill Sepsis Patients
| Status | Completed |
| Phase | N/A |
| Sponsor | Taizhou Hospital |
| Enrollment | 60 |
| Study Type | OBSERVATIONAL |
| Conditions | Sepsis; Hyperglycemia; Glycemic Control |
| Interventions |
Poor glycemic control is common in critically ill patients with sepsis and is associated with increased morbidity and mortality; however, achieving safe and effective glucose management in the ICU remains challenging with conventional intermittent monitoring. Continuous glucose monitoring (CGM) offers real-time interstitial glucose readings and has the potential to improve detection of dysglyce…
NCT06402123 — A Phase 2b Study of Zagociguat in Patients With MELAS
| Status | Completed |
| Phase | Phase 2 |
| Sponsor | Tisento Therapeutics |
| Enrollment | 43 |
| Study Type | INTERVENTIONAL |
| Conditions | Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome) |
| Interventions | ; ; |
PRIZM is a Phase 2b randomized, double-blind, placebo-controlled, 3-treatment, 2-period, crossover study evaluating the efficacy and safety of oral zagociguat 15 and 30 mg vs. placebo when administered daily for 12 weeks in participants with genetically and phenotypically defined MELAS.
Other (Suspended)
NCT02506946 — NAFLD in Adolescents and Young Adults With PCOS
| Status | Suspended |
| Phase | N/A |
| Sponsor | Columbia University |
| Enrollment | 80 |
| Study Type | OBSERVATIONAL |
| Conditions | Polycystic Ovary Syndrome; Non-Alcoholic Fatty Liver Disease; Metabolic Syndrome |
This project focuses on an at-risk adolescent and young adult population who may gain long-term health benefits from detection of risk factors at a young age. The primary aims of this proposal are: 1) To observe whether adolescents and young adults with Polycystic Ovary Syndrome (PCOS) are more likely to have elevated liver fat (>/=4.8%) than controls by studying liver fat deposition measured …
Other (Withdrawn)
NCT05716607 — Treatment Study in Patients Treated With Both Insulin & Hydrocortisone
| Status | Withdrawn |
| Phase | N/A |
| Sponsor | Vastra Gotaland Region |
| Enrollment | N/A |
| Study Type | INTERVENTIONAL |
| Conditions | Diabetes Mellitus; Adrenal Insufficiency; Polyglandular Autoimmune Syndrome |
| Interventions | ; |
The aim of INS.CORT trial is, by studying glycemic variability in a well-defined patient group with both insulin & hydrocortisone (patients with concomitant insulin-treated diabetes & Addison’s disease) and collecting information about the administration -time point and doses- of insulin, hydrocortisone and food intake with the help of new technology to improve the treatment in all patients t…